![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:730863 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC2A8 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | affects expression | ISO | RGD:730863 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of SLC2A8 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:730863 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A8 mRNA | CTD | PMID:17872374 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A8 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A8 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:730862 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A8 mRNA | CTD | PMID:20106945 more ... | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:730863 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A8 mRNA | CTD | PMID:21570461 | 2-acetamidofluorene | multiple interactions | ISO | RGD:730863 | 6480464 | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SLC2A8 mRNA] | CTD | PMID:17317680 | 2-deoxy-D-glucose | increases uptake | EXP | | 6480464 | SLC2A8 protein results in increased uptake of Deoxyglucose | CTD | PMID:23396969 | 2-deoxy-D-glucose | increases uptake | ISO | RGD:730863 | 6480464 | SLC2A8 protein results in increased uptake of Deoxyglucose | CTD | PMID:23396969 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:730863 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SLC2A8 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:730863 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SLC2A8 mRNA | CTD | PMID:30951980 | all-trans-retinoic acid | multiple interactions | ISO | RGD:730863 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SLC2A8 mRNA | CTD | PMID:30951980 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC2A8 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | ISO | RGD:730862 | 6480464 | Antirheumatic Agents results in increased expression of SLC2A8 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:730863 | 6480464 | aristolochic acid I results in decreased expression of SLC2A8 mRNA | CTD | PMID:31009690 | avobenzone | increases expression | ISO | RGD:730862 | 6480464 | avobenzone results in increased expression of SLC2A8 mRNA | CTD | PMID:31016361 | benzo[a]pyrene | increases expression | ISO | RGD:730862 | 6480464 | Benzo(a)pyrene results in increased expression of SLC2A8 mRNA | CTD | PMID:22316170, PMID:26238291 | benzo[a]pyrene | increases methylation | ISO | RGD:730862 | 6480464 | Benzo(a)pyrene results in increased methylation of SLC2A8 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:730863 | 6480464 | Benzo(a)pyrene results in increased methylation of SLC2A8 promoter | CTD | PMID:27901495 | beta-naphthoflavone | increases expression | ISO | RGD:730862 | 6480464 | beta-Naphthoflavone results in increased expression of SLC2A8 mRNA | CTD | PMID:19737606 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC2A8 protein | CTD | PMID:22101236 | bisphenol A | multiple interactions | ISO | RGD:730862 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC2A8 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC2A8 mRNA | CTD | PMID:34947998 | bisphenol A | increases expression | ISO | RGD:730863 | 6480464 | bisphenol A results in increased expression of SLC2A8 mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLC2A8 mRNA | CTD | PMID:25181051 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of SLC2A8 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases expression | ISO | RGD:730862 | 6480464 | Cadmium Chloride results in increased expression of SLC2A8 mRNA | CTD | PMID:26472689 | carbon nanotube | decreases expression | ISO | RGD:730863 | 6480464 | Nanotubes, Carbon results in decreased expression of SLC2A8 mRNA | CTD | PMID:25554681 | chlorpyrifos | increases expression | ISO | RGD:730863 | 6480464 | Chlorpyrifos results in increased expression of SLC2A8 mRNA | CTD | PMID:20350560 | cisplatin | increases expression | ISO | RGD:730862 | 6480464 | Cisplatin results in increased expression of SLC2A8 mRNA | CTD | PMID:27594783 | clofibrate | decreases expression | ISO | RGD:730863 | 6480464 | Clofibrate results in decreased expression of SLC2A8 mRNA | CTD | PMID:17585979, PMID:23811191 | copper(II) sulfate | increases expression | ISO | RGD:730862 | 6480464 | Copper Sulfate results in increased expression of SLC2A8 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | RGD:730862 | 6480464 | Cyclosporine results in increased expression of SLC2A8 mRNA | CTD | PMID:25562108 | D-mannitol | decreases expression | ISO | RGD:730863 | 6480464 | Mannitol results in decreased expression of SLC2A8 mRNA | CTD | PMID:25270620 | decabromodiphenyl ether | decreases expression | ISO | RGD:730863 | 6480464 | decabromobiphenyl ether results in decreased expression of SLC2A8 protein | CTD | PMID:28572024, PMID:31039416 | dehydroascorbic acid | increases uptake | EXP | | 6480464 | SLC2A8 protein results in increased uptake of Dehydroascorbic Acid | CTD | PMID:23396969 | dehydroascorbic acid | increases uptake | ISO | RGD:730863 | 6480464 | SLC2A8 protein results in increased uptake of Dehydroascorbic Acid | CTD | PMID:23396969 | ethanol | increases expression | ISO | RGD:730863 | 6480464 | Ethanol results in increased expression of SLC2A8 mRNA | CTD | PMID:19167417 | ethanol | affects expression | ISO | RGD:730863 | 6480464 | Ethanol affects the expression of SLC2A8 mRNA | CTD | PMID:30319688 | fulvestrant | multiple interactions | ISO | RGD:730862 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC2A8 gene | CTD | PMID:31601247 | fulvestrant | increases methylation | ISO | RGD:730862 | 6480464 | Fulvestrant results in increased methylation of SLC2A8 gene | CTD | PMID:31601247 | gallic acid | decreases expression | ISO | RGD:730862 | 6480464 | Gallic Acid results in decreased expression of SLC2A8 mRNA | CTD | PMID:34408198 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SLC2A8 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | RGD:730862 | 6480464 | Hydrogen Peroxide affects the expression of SLC2A8 mRNA | CTD | PMID:20044591 | ivermectin | increases expression | ISO | RGD:730862 | 6480464 | Ivermectin results in increased expression of SLC2A8 protein | CTD | PMID:32959892 | L-dehydroascorbic acid | increases uptake | EXP | | 6480464 | SLC2A8 protein results in increased uptake of Dehydroascorbic Acid | CTD | PMID:23396969 | L-dehydroascorbic acid | increases uptake | ISO | RGD:730863 | 6480464 | SLC2A8 protein results in increased uptake of Dehydroascorbic Acid | CTD | PMID:23396969 | leflunomide | increases expression | ISO | RGD:730862 | 6480464 | leflunomide results in increased expression of SLC2A8 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | RGD:730862 | 6480464 | Methyl Methanesulfonate results in increased expression of SLC2A8 mRNA | CTD | PMID:23649840 | monosodium L-glutamate | multiple interactions | ISO | RGD:730863 | 6480464 | [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC2A8 mRNA | CTD | PMID:19001666 | paracetamol | increases expression | ISO | RGD:730862 | 6480464 | Acetaminophen results in increased expression of SLC2A8 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC2A8 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:730863 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC2A8 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC2A8 mRNA | CTD | PMID:36331819 | pirinixic acid | multiple interactions | ISO | RGD:730862 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC2A8 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | RGD:730863 | 6480464 | pirinixic acid results in decreased expression of SLC2A8 mRNA | CTD | PMID:23811191 | quercetin | increases expression | ISO | RGD:730862 | 6480464 | Quercetin results in increased expression of SLC2A8 mRNA | CTD | PMID:21632981 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of SLC2A8 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | RGD:730862 | 6480464 | Sunitinib results in decreased expression of SLC2A8 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | RGD:730862 | 6480464 | Temozolomide results in increased expression of SLC2A8 mRNA | CTD | PMID:31758290 | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of SLC2A8 mRNA | CTD | PMID:21515302 | testosterone | decreases expression | ISO | RGD:730862 | 6480464 | Testosterone results in decreased expression of SLC2A8 mRNA | CTD | PMID:33359661 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SLC2A8 mRNA | CTD | PMID:16239168, PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC2A8 mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC2A8 mRNA | CTD | PMID:33387578 | triptonide | increases expression | ISO | RGD:730863 | 6480464 | triptonide results in increased expression of SLC2A8 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | ISO | RGD:730863 | 6480464 | trovafloxacin results in decreased expression of SLC2A8 mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | RGD:730863 | 6480464 | Valproic Acid affects the expression of SLC2A8 mRNA | CTD | PMID:17292431 | zidovudine | increases expression | ISO | RGD:730862 | 6480464 | Zidovudine results in increased expression of SLC2A8 mRNA | CTD | PMID:24292225 | |